Insider holders · CIK 0001541157
Akari Therapeutics Plc · AKTX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| RPC Pharma Ltd10% Owner | 722,345,600 | — | 722,345,600 | Sep 23, 2015 · 10:38 am EDT | Form 3 |
| Ray PrudoDirector | — | 722,345,600 | 722,345,600 | Sep 23, 2015 · 10:40 am EDT | Form 3 |
| Stuart UngarDirector | — | 722,345,600 | 722,345,600 | Sep 23, 2015 · 10:38 am EDT | Form 3 |
| James HillDirector | — | 722,345,600 | 722,345,600 | Sep 23, 2015 · 10:37 am EDT | Form 3 |
| Mark S CohenDirector | 1,055,600 | — | 1,055,600 | Sep 22, 2015 · 5:42 pm EDT | Form 4 |
| Gur RoshwalbChief Executive Officer | 175,438 | — | 175,438 | Jan 2, 2015 · 6:17 am EST | Form 3 |
| Samir Rashmikant PatelDirector | 3,566 | 98,241 | 101,807 | Jul 17, 2026 · 6:03 am EDT | Form 4 |
| David SidranskyDirector | 54,732 | — | 54,732 | Jan 2, 2015 · 6:10 am EST | Form 3 |
| Allan ShawDirector | 33,530 | — | 33,530 | Jan 2, 2015 · 6:04 am EST | Form 3 |
| Kameel D. FaragInterim CFO | 23,309 | — | 23,309 | Aug 19, 2026 · 5:00 pm EDT | Form 4 |
| Clive RichardsonCOO | 0 | — | 0 | Sep 23, 2015 · 10:39 am EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.